• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl alcohols

Research Briefing on 3-Chloro-5-(hydroxymethyl)phenol (CAS: 885270-34-8): Recent Advances and Applications in Chemical Biology and Pharmaceutical Sciences

3-Chloro-5-(hydroxymethyl)phenol (CAS: 885270-34-8) is a chlorinated phenolic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its hydroxymethyl and chloro functional groups, serves as a key intermediate in the synthesis of various bioactive molecules and pharmaceutical agents. Recent studies have explored its potential in antimicrobial, antifungal, and anti-inflammatory applications, as well as its role in the development of novel drug delivery systems. This briefing provides an overview of the latest research findings and technological advancements related to this compound.

A recent study published in the Journal of Medicinal Chemistry investigated the antimicrobial properties of 3-chloro-5-(hydroxymethyl)phenol and its derivatives. The research team synthesized a series of analogs and evaluated their efficacy against a panel of Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli. The results demonstrated that certain derivatives exhibited potent antibacterial activity, with minimum inhibitory concentrations (MICs) comparable to those of established antibiotics. The study also highlighted the compound's potential as a scaffold for the development of new antimicrobial agents, particularly in the face of rising antibiotic resistance.

In another groundbreaking study, researchers explored the compound's role in the synthesis of polymer-based drug delivery systems. By incorporating 3-chloro-5-(hydroxymethyl)phenol into biodegradable polymers, the team developed a novel nanocarrier system capable of targeted drug delivery. The hydroxymethyl group facilitated covalent conjugation with therapeutic agents, while the chloro group enhanced the stability of the polymer matrix. In vitro and in vivo experiments revealed that this system significantly improved the bioavailability and therapeutic efficacy of encapsulated drugs, particularly in cancer treatment. These findings were published in the journal Advanced Materials and have sparked interest in the compound's potential for personalized medicine.

Further investigations into the compound's anti-inflammatory properties have also yielded promising results. A study conducted by a team at the University of Cambridge demonstrated that 3-chloro-5-(hydroxymethyl)phenol could modulate key inflammatory pathways, including the NF-κB signaling cascade. The compound was shown to inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, suggesting its potential as a lead compound for the development of anti-inflammatory therapeutics. These findings were corroborated by molecular docking studies, which revealed strong interactions between the compound and inflammatory mediators.

Despite these advancements, challenges remain in the large-scale synthesis and application of 3-chloro-5-(hydroxymethyl)phenol. Recent efforts have focused on optimizing synthetic routes to improve yield and purity. A study published in Organic Process Research & Development detailed a novel catalytic process that significantly enhanced the efficiency of the compound's synthesis. The use of green chemistry principles, such as solvent-free reactions and recyclable catalysts, was emphasized, aligning with the growing demand for sustainable pharmaceutical manufacturing practices.

In conclusion, 3-chloro-5-(hydroxymethyl)phenol (CAS: 885270-34-8) represents a promising compound with diverse applications in chemical biology and pharmaceutical sciences. Recent research has underscored its potential in antimicrobial therapy, drug delivery, and anti-inflammatory treatments, while also addressing synthetic challenges. As the field continues to evolve, further studies are warranted to fully exploit the compound's therapeutic potential and translate these findings into clinical applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)